457 related articles for article (PubMed ID: 10786828)
1. Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.
Safadi FF; Hermey DC; Popoff SN; Seifert MF
Endocrine; 1999 Dec; 11(3):309-19. PubMed ID: 10786828
[TBL] [Abstract][Full Text] [Related]
2. Interdependence of skeletal sclerosis and elevated circulating levels of 1,25-dihydroxyvitamin D in osteopetrotic (op and tl) rats.
Popoff SN; Osier LK; Zerwekh JE; Marks SC
Bone; 1994; 15(5):515-22. PubMed ID: 7980962
[TBL] [Abstract][Full Text] [Related]
3. Effects of 1,25-dihydroxyvitamin D3 on bone resorption and natural immunity in osteopetrotic (ia) rats.
Schneider GB; Relfson M; Langman CB
J Bone Miner Res; 1994 Apr; 9(4):585-91. PubMed ID: 8030447
[TBL] [Abstract][Full Text] [Related]
4. Osteoblasts from the toothless (osteopetrotic) mutation in the rat are unable to direct bone resorption by normal osteoclasts in response to 1,25-dihydroxyvitamin D.
Sundquist KT; Jackson ME; Hermey DC; Marks SC
Tissue Cell; 1995 Oct; 27(5):569-74. PubMed ID: 7491626
[TBL] [Abstract][Full Text] [Related]
5. Effects of 1,25 dihydroxyvitamin D on osteoclast number and cytochemistry in normal and osteopetrotic (os) rabbits.
Grise MA; Marks SC; MacKay CA; Popoff SN
Am J Anat; 1990 Nov; 189(3):261-6. PubMed ID: 2148052
[TBL] [Abstract][Full Text] [Related]
6. Regulation of mineral homeostasis in osteopetrotic (op) rats.
Hermey DC; Ireland RA; Zerwekh JE; Popoff SN
Am J Physiol; 1995 Feb; 268(2 Pt 1):E312-7. PubMed ID: 7864108
[TBL] [Abstract][Full Text] [Related]
7. Treatment of congenital osteopetrosis in the rabbit with high-dose 1,25-dihydroxyvitamin D.
Popoff SN; McGuire JL; Zerwekh JE; Marks SC
J Bone Miner Res; 1989 Feb; 4(1):57-67. PubMed ID: 2718779
[TBL] [Abstract][Full Text] [Related]
8. Osteopetrosis in the rat: coexistence of reductions in osteocalcin and bone resorption.
Lian JB; Marks SC
Endocrinology; 1990 Feb; 126(2):955-62. PubMed ID: 2298176
[TBL] [Abstract][Full Text] [Related]
9. Expression of the vitamin D receptor in the intestine and kidney of osteopetrotic rats.
Hermey DC; Popoff SN
Endocrinology; 1995 Oct; 136(10):4558-64. PubMed ID: 7664677
[TBL] [Abstract][Full Text] [Related]
10. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
Yao J; Kathpalia P; Bushinsky DA; Favus MJ
J Clin Invest; 1998 May; 101(10):2223-32. PubMed ID: 9593778
[TBL] [Abstract][Full Text] [Related]
11. Reduced bone resorption in toothless (osteopetrotic) rats--an abnormality of osteoblasts related to their inability to activate osteoclast activity in vitro.
Hermey DC; Popoff SN; Marks SC
Connect Tissue Res; 1996; 35(1-4):273-8. PubMed ID: 9084666
[TBL] [Abstract][Full Text] [Related]
12. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
Mortensen BM; Gautvik KM; Gordeladze JO
Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of osteoclasts in osteopetrotic mice is due to a defect in the local microenvironment provided by osteoblastic cells.
Takahashi N; Udagawa N; Akatsu T; Tanaka H; Isogai Y; Suda T
Endocrinology; 1991 Apr; 128(4):1792-6. PubMed ID: 2004603
[TBL] [Abstract][Full Text] [Related]
14. Effect of dietary calcium on the response of bone to 1,25 (OH)2D3.
Boyce RW; Weisbrode SE
Lab Invest; 1983 Jun; 48(6):683-9. PubMed ID: 6687909
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities of phosphoprotein gene expression in three osteopetrotic rat mutations: elevated mRNA transcripts, protein synthesis, and accumulation in bone of mutant animals.
Shalhoub V; Bettencourt B; Jackson ME; MacKay CA; Glimcher MJ; Marks SC; Stein GS; Lian JB
J Cell Physiol; 1994 Jan; 158(1):110-20. PubMed ID: 8263018
[TBL] [Abstract][Full Text] [Related]
16. 1,25-dihydroxyvitamin D3 as well as its analogue OCT lower blood calcium through inhibition of bone resorption in hypercalcemic rats with continuous parathyroid hormone-related peptide infusion.
Endo K; Katsumata K; Hirata M; Masaki T; Kubodera N; Nakamura T; Ikeda K; Ogata E
J Bone Miner Res; 2000 Jan; 15(1):175-81. PubMed ID: 10646127
[TBL] [Abstract][Full Text] [Related]
17. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
[TBL] [Abstract][Full Text] [Related]
18. Reduced osteoblastic population and defective mineralization in osteopetrotic (op/op) mice.
Sakagami N; Amizuka N; Li M; Takeuchi K; Hoshino M; Nakamura M; Nozawa-Inoue K; Udagawa N; Maeda T
Micron; 2005; 36(7-8):688-95. PubMed ID: 16182547
[TBL] [Abstract][Full Text] [Related]
19. Cultured circulating mononuclear cells from osteopetrotic infants express the osteoclast-associated vitronectin receptor and form multinucleated cells in response to 1,25-dihydroxyvitamin D3.
Cournot G; Petrovic M; Trubert CL; Cormier C; Girault D; Fischer A; Garabedian M
J Bone Miner Res; 1993 Jan; 8(1):61-70. PubMed ID: 7678950
[TBL] [Abstract][Full Text] [Related]
20. Chronic administration of 1,25-dihydroxyvitamin D3: increased bone but impaired mineralization.
Wronski TJ; Halloran BP; Bikle DD; Globus RK; Morey-Holton ER
Endocrinology; 1986 Dec; 119(6):2580-5. PubMed ID: 3780540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
